A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women
Open Access
- 1 January 2009
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (1) , 3-8
Abstract
OBJECTIVE—Subclinical inflammation is linked with the development of type 2 diabetes, and epidemiologic data suggest that this association may be stronger in women. Although small clinical studies have shown a prominent hypoglycemic effect of short-term high-dose aspirin, no randomized trials have directly evaluated the efficacy of aspirin in diabetes prevention at doses acceptable for use in routine clinical practice. We evaluated whether chronic low-dose aspirin prevents the development of clinical diabetes among initially healthy American women. RESEARCH DESIGN AND METHODS—Subjects were enrolled in the Women's Health Study, a 10-year randomized double-blind, placebo-controlled trial of aspirin and vitamin E for primary prevention of cardiovascular disease and cancer. Between 1992 and 1995, 38,716 women aged ≥45 years and free of clinical diabetes were randomly assigned to either low-dose aspirin or placebo (median follow-up 10.2 years). Documented clinical type 2 diabetes was prospectively evaluated throughout the trial. RESULTS—Among women randomly assigned to receive aspirin (n = 19,326) or placebo (n = 19,390), there was no statistically significant difference in the incidence of type 2 diabetes. There were 849 cases of diabetes in the aspirin group and 847 in the placebo group (rate ratio 1.01 [95% CI 0.91–1.11]). Stratification by diabetes risk factors including age, BMI, family history of diabetes, physical activity, A1C, and high-sensitivity C-reactive protein did not support a modulating effect of these variables. Analyses accounting for treatment duration and adherence similarly found no beneficial effects. CONCLUSIONS—These data suggest that long-term low-dose aspirin does not prevent the development of clinical type 2 diabetes in initially healthy women.Keywords
This publication has 25 references indexed in Scilit:
- Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young AdultsDiabetes Care, 2008
- Accuracy of Administrative Coding for Type 2 Diabetes in Children, Adolescents, and Young AdultsDiabetes Care, 2007
- Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory MarkersDiabetes Care, 2007
- Vitamin E and Risk of Type 2 Diabetes in the Women’s Health Study Randomized Controlled TrialDiabetes, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Thromboxane-Dependent CD40 Ligand Release in Type 2 Diabetes MellitusJACC, 2006
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005
- Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of IkkβScience, 2001
- Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjectsDiabetes, 1978
- The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal manDiabetologia, 1978